Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,000
Closed -$255K 1220
2022
Q3
$255K Sell
15,000
-34,000
-69% -$730K ﹤0.01% 1098
2022
Q2
$1.05M Hold
49,000
0.01% 835
2022
Q1
$1.81M Hold
49,000
0.01% 746
2021
Q4
$2.23M Sell
49,000
-58,600
-54% -$3.06M 0.01% 705
2021
Q3
$6.82M Buy
107,600
+42,480
+65% +$3.23M 0.05% 432
2021
Q2
$5.96M Buy
65,120
+14,964
+30% +$1.19M 0.04% 473
2021
Q1
$3.42M Buy
50,156
+22,500
+81% +$1.75M 0.02% 605
2020
Q4
$2M Sell
27,656
-3,500
-11% -$203K 0.01% 710
2020
Q3
$1.18M Buy
31,156
+6,156
+25% +$208K 0.01% 786
2020
Q2
$886K Buy
+25,000
New +$711K 0.01% 822
2017
Q2
Sell
-51,694
Closed -$72K 1135
2017
Q1
$72K Hold
51,694
﹤0.01% 1125
2016
Q4
$140K Sell
51,694
-15,738
-23% -$54.5K ﹤0.01% 1114
2016
Q3
$239K Sell
67,432
-4,240
-6% -$19.5K ﹤0.01% 1106
2016
Q2
$309K Hold
71,672
﹤0.01% 1084
2016
Q1
$355K Sell
71,672
-3,476
-5% -$17.8K ﹤0.01% 1045
2015
Q4
$481K Sell
75,148
-49,852
-40% -$271K ﹤0.01% 1008
2015
Q3
$521K Hold
125,000
﹤0.01% 937
2015
Q2
$813K Hold
125,000
﹤0.01% 907
2015
Q1
$693K Hold
125,000
﹤0.01% 930
2014
Q4
$906K Hold
125,000
﹤0.01% 893
2014
Q3
$875K Buy
+125,000
New +$1.2M ﹤0.01% 911

Other funds holding CDNA

Gabelli Funds's CDNA Position: Q4 2022 in Review

Gabelli Funds sold out of CareDx (CDNA) in Q4 2022, closing a stake of 15,000 shares — an estimated $255K sold.

Gabelli Funds first reported a position in CDNA in Q3 2014 and held it in 21 quarters. The position peaked at $6.82M in Q3 2021. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

  • Gabelli Funds reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
  • Gabelli Funds sold 15,000 CareDx shares in Q4 2022, an estimated $255K.
  • Gabelli Funds first reported a position in CareDx in Q3 2014 and held it in 21 quarters.
  • Gabelli Funds's CareDx position peaked at $6.82M in Q3 2021.
  • 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on Gabelli Funds's 13F filing for Q4 2022, filed 13 Feb 2023.